NTF4 and cancer: In any case, when the same drug-armed NT4 peptides were tested in vivo in different animal models of human cancers, they resulted much more efficient than the correspondent unconjugated drug in inhibiting tumor growth or even inducing regression up to clearance of the disease [10, 12, 15].